Department of Otorhinolaryngology-Head and Neck Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Otolaryngol Head Neck Surg. 2013 Oct;149(4):596-602. doi: 10.1177/0194599813495664. Epub 2013 Jul 11.
Currently, a variety of materials are available for the treatment of glottal insufficiency. Ideal injection materials should be inexpensive, easily obtainable, nontoxic, and biocompatible. Plasma gel has recently been developed as an injectable, autologous material used in plastic surgery. The aim of this study was to evaluate the histological changes in rabbit vocal folds (VFs) after an injection of plasma gel, compared with collagen (Artecoll) or hyaluronic acid (Reviderm Intra).
Experimental prospective animal study.
Animal laboratory.
Blood samples were collected from 12 New Zealand rabbits. Plasma collected from each rabbit was centrifuged and processed using a gel heating system. All rabbits received a 0.05 ml injection of plasma gel into the right VF, while an equivalent volume of Artecoll or Reviderm Intra was injected into the left VFs of each 6 rabbits randomly. The larynges were collected 2, 4, and 8 weeks after injection, and the tissues were stained for histological analysis.
In comparison with left VFs injected with Artecoll or Reviderm Intra, there was significantly less inflammatory response and foreign body reaction in the plasma gel injected right VFs (P < .05). Multinucleated foreign body type giant cells were also more prevalent in the left VFs. There were no quantitative differences in the rates of neovascularization or collagen deposition between groups.
Plasma gel is a biologically compatible material that may serve as a suitable augmentation material in injection laryngoplasty. Further studies that examine the long-term effects in a larger number of subjects are needed.
目前有多种材料可用于治疗声门不全。理想的注射材料应该是廉价、易得、无毒和生物相容的。等离子凝胶最近已被开发为一种可注射的、自体的用于整形手术的材料。本研究旨在评估兔声带(VF)注射等离子凝胶后的组织学变化,并与胶原(Artecoll)或透明质酸(Reviderm Intra)进行比较。
实验性前瞻性动物研究。
动物实验室。
从 12 只新西兰兔中采集血样。从每只兔子采集的血浆经离心后,采用凝胶加热系统进行处理。所有兔子的右侧 VF 注射 0.05ml 等离子凝胶,而每 6 只兔子的左侧 VF 随机注射等量的 Artecoll 或 Reviderm Intra。注射后 2、4 和 8 周采集喉组织,进行组织学分析。
与左侧 VF 注射 Artecoll 或 Reviderm Intra 相比,右侧 VF 注射等离子凝胶的炎症反应和异物反应明显较轻(P <.05)。左侧 VF 中也更常见多核异物型巨细胞。各组间新生血管形成或胶原沉积的速度无定量差异。
等离子凝胶是一种生物相容性材料,可作为注射性喉成形术的合适填充材料。需要进一步研究以评估其在更大样本量中的长期效果。